Analystreport

Conatus Pharmaceuticals Inc (NASDAQ: CNAT) had its "buy" rating re-affirmed by analysts at HC Wainwright.

CONATUS PHARMACEUTICALS INC  (CNAT) 
Last conatus pharmaceuticals inc earnings: 11/5 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.conatuspharma.com/investor-relations